Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kuwait Business Journal.
Press releases published on August 14, 2025
Sarepta Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; August 25, 2025 Deadline to file Lead Plaintiff Motion
GlobeNewswire
·
August 14, 2025
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sarepta Therapeutics, Inc. ("Sarepta Therapeutics" or the "Company") (NASDAQ: SRPT) …
BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for …
Martin Marietta Increases Quarterly Cash Dividend
GlobeNewswire
·
August 14, 2025
RALEIGH, N.C., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE: MLM) (“Martin Marietta” or the “Company”) today announced that its Board of Directors approved an increase in its quarterly cash dividend, raising it from $0.79 per …
Shuttle Pharma Provides Second Quarter 2025 Corporate Update
GlobeNewswire
·
August 14, 2025
GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
CMMB, with P&G Support, Responds to Deadly Cholera and Hunger Crisis in South Sudan
GlobeNewswire
·
August 14, 2025
Juba, South Sudan, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Catholic Medical Mission Board (CMMB) is launching an emergency response in South Sudan as compounding crises threaten thousands of lives in Upper Nile region and Central Equatoria State. The devastating …
Shimmick Corporation Announces Second Quarter 2025 Results
GlobeNewswire
·
August 14, 2025
IRVINE, Ca., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transportation, today announced financial results for the second …
Diginex Announces extension of Resulticks MOU
GlobeNewswire
·
August 14, 2025
LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced that, by mutual consent, the Company and Resulticks Global Companies Pte. …
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
August 14, 2025
Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of …
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, 2025 anticipated to fund key milestones through mid-2026 REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bolt …
Birchtech Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
Second Quarter 2025 Revenues Totaled $3.3 Million, Driven by Continued Industry Recognition of Intellectual Property Portfolio CORSICANA, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) ("Birchtech" or the "Company"), a …
GT Biopharma Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
GTB-3650 TriKE® Phase 1 trial has successfully completed Cohort 1 and Cohort 2 dosing, treating a total of four patients; following Cohort 2’s formal safety review, it has advanced into Cohort 3 and initiated dosing of the fifth patient in the study; …
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
– Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with preliminary data in second half of 2025 and first half of 2026 – Phase 1/ …
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
GlobeNewswire
·
August 14, 2025
Presented positive translational data from SYNGAP1-related disorders program showcasing efficacy in a humanized SYNGAP mouse model and increased protein in non-human primates at the 28th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting …
Magnite to Participate in Upcoming Financial Conferences
GlobeNewswire
·
August 14, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host investor meetings at the following financial conferences …
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
GlobeNewswire
·
August 14, 2025
PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Trust Stamp files its 2025 Q2 10-Q and announced continued growth in OL Platform Registrations and a Key Performance Metric
GlobeNewswire
·
August 14, 2025
Atlanta, GA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) announced that: It filed its Q2 10-Q report for the six months ended 30 June 2025 after the Nasdaq market closed on August 14th, 2025. Net recognised revenue for the three months …
Venus Concept Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2025. Summary of …
Nasus Pharma Announces Closing of Initial Public Offering
GlobeNewswire
·
August 14, 2025
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
August 14, 2025
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Exemption submission to FDA of novel CBGM technology in Q4 …
SL Green Realty Corp. to Present at the BofA Securities 2025 Global Real Estate Conference on September 10, 2025
GlobeNewswire
·
August 14, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG), New York City’s largest office landlord, today announced that Matt DiLiberto, Chief Financial Officer, Harrison Sitomer, Chief Investment Officer, and Steven Durels, Executive …